Marion Gayral
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells.
Journal: Communications biology
Published: November 13, 2023
Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.
Journal: Human gene therapy
Published: January 06, 2016
Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.
Journal: EMBO molecular medicine
Published: April 03, 2015
TOM1 is a PI5P effector involved in the regulation of endosomal maturation.
Journal: Journal of cell science
Published: January 16, 2015
First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 09, 2014
Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.
Journal: Human gene therapy
Published: November 26, 2014
Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.
Journal: World journal of gastroenterology
Published: October 28, 2013
MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.
Journal: World journal of gastroenterology
Published: October 24, 2013
Targeting miR-21 for the therapy of pancreatic cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 14, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026